Login

Daxas 250 mcg Film-Coated Tablets

Product Information *

  • Company:

    AstraZeneca Pharmaceuticals (Ireland) DAC

  • Status:

    No Recent Update

  • Active Ingredients :

    roflumilast

    This medicinal product is subject to additional monitoring.

    *Additional information is available upon request

  • Legal Category:

    Product subject to medical prescription which may be renewed (B)
  • undefined
  • undefined
  • undefined
  • undefined

  • What is a Patient Information leaflet and why is it useful?

    A Patient Information Leaflet (PIL) is the leaflet containing information on taking or using a medicine for patients, included with medicine packaging. It is written by pharmaceutical companies as a patient version of the Summary of Product Characteristics (SPC). Changes to the PIL after your medicine was packed may mean the version on medicines.ie may differ from the version found with your medicine.

  • 20200904 Package Leaflet IE MT Daxas Tablets 250mcg Addition of Corden as BR site RSP 20 0020

    Last updated: 11/09/20